Caxton Associates (New York)’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,479
Closed -$328K 492
2019
Q2
$328K Buy
+3,479
New +$297K 0.04% 269
2017
Q4
Sell
-6,500
Closed -$283K 475
2017
Q3
$283K Buy
+6,500
New +$253K 0.01% 441

Other funds holding NOVT

Caxton Associates (New York)'s NOVT Position: Q3 2019 in Review

Caxton Associates (New York) sold out of Novanta (NOVT) in Q3 2019, closing a stake of 3,479 shares — an estimated $328K sold.

Caxton Associates (New York) first reported a position in NOVT in Q3 2017 and held it in 2 quarters. The position peaked at $328K in Q2 2019. 169 funds tracked by Wall St. Rank hold NOVT as of Q3 2019.

  • Caxton Associates (New York) reported no remaining Novanta position as of Q3 2019 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,479 Novanta shares in Q3 2019, an estimated $328K.
  • Caxton Associates (New York) first reported a position in Novanta in Q3 2017 and held it in 2 quarters.
  • Caxton Associates (New York)'s Novanta position peaked at $328K in Q2 2019.
  • 169 funds tracked by Wall St. Rank held Novanta as of Q3 2019.

Based on Caxton Associates (New York)'s 13F filing for Q3 2019, filed 14 Nov 2019.